Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma.
about
Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10.Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling.
P2860
Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@en
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@nl
type
label
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@en
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@nl
prefLabel
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@en
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Expression of oncofetal antige ...... ated hepatocellular carcinoma.
@en
P2093
P2860
P304
42150-42158
P356
10.18632/ONCOTARGET.9892
P407
P577
2016-06-07T00:00:00Z